Ionis Pharmaceuticals IONS Pre-Tax Income (Foreign)
Pre-Tax Income (Foreign) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's pre-tax income (foreign).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's pre-tax income (foreign)?
- Ionis Pharmaceuticals (IONS) reported pre-tax income (foreign) of $394.75K in Q4 2025.
- How has Ionis Pharmaceuticals's pre-tax income (foreign) changed year-over-year?
- Ionis Pharmaceuticals's pre-tax income (foreign) increased by 145.2% year-over-year, from $161K to $394.75K.
- What is the long-term trend for Ionis Pharmaceuticals's pre-tax income (foreign)?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's pre-tax income (foreign) has grown at a 45.9% compound annual growth rate (CAGR), from $742K to $1.58M.
- What does pre-tax income (foreign) mean?
- Pre-tax profit or loss generated solely from international business activities.
- How do you interpret pre-tax income (foreign)?
- Growth in this metric indicates successful international expansion or improved performance in foreign markets.
- How does pre-tax income (foreign) compare across companies?
- Commonly reported by multinational corporations to distinguish domestic versus international performance.